Ziprasidone + Sertraline
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Social Anxiety Disorder
Conditions
Social Anxiety Disorder
Trial Timeline
Nov 1, 2004 → Jul 1, 2009
NCT ID
NCT00215150About Ziprasidone + Sertraline
Ziprasidone + Sertraline is a phase 2 stage product being developed by Pfizer for Social Anxiety Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00215150. Target conditions include Social Anxiety Disorder.
What happened to similar drugs?
7 of 16 similar drugs in Social Anxiety Disorder were approved
Approved (7) Terminated (4) Active (6)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00215150 | Phase 2 | Completed |
Competing Products
20 competing products in Social Anxiety Disorder
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| LY686017 + paroxetine + placebo | Eli Lilly | Phase 2 | 35 |
| atomoxetine + placebo | Eli Lilly | Phase 2/3 | 38 |
| ONO-1110 + Placebo | Ono Pharmaceutical | Phase 2 | 39 |
| Cariprazine + Placebo | AbbVie | Approved | 43 |
| Quetiapine | AstraZeneca | Approved | 43 |
| quetiapine | AstraZeneca | Phase 3 | 32 |
| quetiapine | AstraZeneca | Phase 2/3 | 38 |
| Seroquel + Sugar Pill | AstraZeneca | Phase 3 | 40 |
| quetiapine | AstraZeneca | Approved | 43 |
| Pristiq + Placebo | Pfizer | Approved | 43 |
| Venlafaxine ER | Pfizer | Phase 3 | 40 |
| Sertraline + Placebo | Pfizer | Approved | 35 |
| Nefazodone | Bristol Myers Squibb | Approved | 43 |
| Escitalopram | Lundbeck | Approved | 40 |
| Cipralex + Placebo | Lundbeck | Phase 2 | 32 |
| BHV-0223 + Placebo | Biohaven | Phase 2/3 | 32 |
| VQW-765 + Placebo | Vanda Pharmaceuticals | Phase 3 | 37 |
| PH94B | Vistagen Therapeutics | Phase 3 | 22 |
| Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray | Vistagen Therapeutics | Phase 2 | 32 |
| PH94B Nasal Spray + Placebo Nasal Spray | Vistagen Therapeutics | Phase 3 | 22 |